Harbour Capital Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,550	Closed	-$242K	–	280
2024 Q4	$242K	Hold	4,550	–	–	0.05%	257
2024 Q3	$231K	Hold	4,550	–	–	0.05%	261
2024 Q2	$210K	Buy	+4,550	New	+$210K	0.05%	265